chr19-3905514-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_033064.5(ATCAY):c.217G>A(p.Asp73Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033064.5 missense
Scores
Clinical Significance
Conservation
Publications
- cerebellar ataxiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Cayman type cerebellar ataxiaInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATCAY | NM_033064.5 | c.217G>A | p.Asp73Asn | missense_variant | Exon 4 of 13 | ENST00000450849.7 | NP_149053.1 | |
ATCAY | XM_047439578.1 | c.-171G>A | 5_prime_UTR_variant | Exon 3 of 12 | XP_047295534.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.217G>A (p.D73N) alteration is located in exon 4 (coding exon 3) of the ATCAY gene. This alteration results from a G to A substitution at nucleotide position 217, causing the aspartic acid (D) at amino acid position 73 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at